Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia

NCT04902781 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Classic Galactosemia

Interventions

DRUG: AT-007
OTHER: Placebo

Sponsor

Applied Therapeutics, Inc.